These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1332 related articles for article (PubMed ID: 26291816)
1. Are serum chemerin levels different between obese and non-obese polycystic ovary syndrome women? Yang S; Wang Q; Huang W; Song Y; Feng G; Zhou L; Tan J Gynecol Endocrinol; 2016; 32(1):38-41. PubMed ID: 26291816 [TBL] [Abstract][Full Text] [Related]
2. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome. Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370 [TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study. Singh S; Akhtar N; Ahmad J Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540 [TBL] [Abstract][Full Text] [Related]
4. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
5. Serum chemerin level in women with PCOS and its relation with the risk of spontaneous abortion. Yang X; Quan X; Lan Y; Wei Q; Ye J; Yin X; Ji Z; Xing H; Yang Y Gynecol Endocrinol; 2018 Oct; 34(10):864-867. PubMed ID: 29658354 [TBL] [Abstract][Full Text] [Related]
6. Chemerin as a marker of body fat and insulin resistance in women with polycystic ovary syndrome. Kort DH; Kostolias A; Sullivan C; Lobo RA Gynecol Endocrinol; 2015 Feb; 31(2):152-5. PubMed ID: 25295622 [TBL] [Abstract][Full Text] [Related]
7. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome. Pehlivanov B; Mitkov M Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711 [TBL] [Abstract][Full Text] [Related]
8. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Holte J; Bergh T; Berne C; Lithell H Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457 [TBL] [Abstract][Full Text] [Related]
9. Elevated serum chemerin in Chinese women with hyperandrogenic PCOS. Wang L; Zhong Y; Ding Y; Shi X; Huang J; Zhu F Gynecol Endocrinol; 2014 Oct; 30(10):746-50. PubMed ID: 24927079 [TBL] [Abstract][Full Text] [Related]
10. Is serum leptin level regulated by thyroid functions, lipid metabolism and insulin resistance in polycystic ovary syndrome? Erel CT; Senturk LM; Kaleli S; Gezer A; Baysal B; Tasan E Gynecol Endocrinol; 2003 Jun; 17(3):223-9. PubMed ID: 12857430 [TBL] [Abstract][Full Text] [Related]
11. Higher levels of circulating chemerin in both lean and obese patients with polycystic ovary syndrome. Ademoglu E; Berberoglu Z; Carlioglu A; Dellal F; Gorar S; Alphan Z; Uysal S; Karakurt F Minerva Ginecol; 2014 Dec; 66(6):535-42. PubMed ID: 25373013 [TBL] [Abstract][Full Text] [Related]
12. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome]. Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713 [TBL] [Abstract][Full Text] [Related]
13. Circulating anti-Müllerian hormone levels in relation to nutritional status and selected adipokines levels in polycystic ovary syndrome. Olszanecka-Glinianowicz M; Madej P; Owczarek A; Chudek J; Skałba P Clin Endocrinol (Oxf); 2015 Jul; 83(1):98-104. PubMed ID: 25440474 [TBL] [Abstract][Full Text] [Related]
14. Association of lipid profile and obesity in patients with polycystic ovary syndrome. Parveen S; Khan S; Khan MM; Gupta B; Ahmad A; Alam R Endocr Regul; 2024 Jan; 58(1):83-90. PubMed ID: 38656255 [No Abstract] [Full Text] [Related]
15. The correlation between serum adipokines levels and metabolic indicators in girls with Turner syndrome. Zhang Y; Chen RM; Lin XQ; Yuan X; Yang XH Cytokine; 2019 Jan; 113():139-143. PubMed ID: 29983357 [TBL] [Abstract][Full Text] [Related]
16. Metabolic effect of obesity on polycystic ovary syndrome in adolescents: a meta-analysis. Li L; Feng Q; Ye M; He Y; Yao A; Shi K J Obstet Gynaecol; 2017 Nov; 37(8):1036-1047. PubMed ID: 28657375 [TBL] [Abstract][Full Text] [Related]
17. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome. Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948 [TBL] [Abstract][Full Text] [Related]
18. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649 [TBL] [Abstract][Full Text] [Related]
19. Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance. Yang S; Li Q; Zhong L; Song Y; Tian B; Cheng Q; Qing H; Xia W; Luo M; Mei M J Clin Endocrinol Metab; 2011 Mar; 96(3):831-6. PubMed ID: 21209034 [TBL] [Abstract][Full Text] [Related]
20. Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome. Ducluzeau PH; Cousin P; Malvoisin E; Bornet H; Vidal H; Laville M; Pugeat M J Clin Endocrinol Metab; 2003 Aug; 88(8):3626-31. PubMed ID: 12915646 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]